Stryker is one of the world's leading medical technology companies, offering innovative products and services that help improve patient and hospital outcomes. The COVID-19 pandemic has led to severe disruptions in the market and the global economy, adversely affecting operations and financial results. The response to the pandemic has included unprecedented measures that have significantly impacted Stryker's operations, including the postponement of elective medical procedures. In 2020, reported net sales declined 3.6%, and net earnings decreased significantly, reflecting the challenges faced during the pandemic. The company continued its capital allocation strategy by investing in acquisitions, which are essential for enhancing its technology capabilities and supporting business strategies. Research, development, and engineering expenses increased, reflecting investments in new technologies and integration of recent acquisitions. Selling, general, and administrative expenses included charges related to the development of a new global ERP system, which is critical for enhancing information management capabilities and operational efficiency. The integration of technology resources and the focus on operational flexibility are vital for Stryker to navigate market dynamics and maintain competitive advantage. The company's ability to mobilize and deploy IT-based resources in combination with other capabilities is crucial for transforming its operations and achieving business goals. The financial condition remains strong, supported by substantial cash from operations and access to capital markets, which facilitates ongoing investments in technology and innovation. Despite the pandemic-related challenges, Stryker anticipates being able to support its liquidity and operational needs through various sources, including cash from operations and existing credit lines. The company maintains a revolving credit facility that provides additional financial flexibility. The strategic focus on enhancing IT capabilities and integrating technology into operations is essential for Stryker to respond to evolving business needs and market conditions. The ongoing commitment to innovation and technology deployment will play a significant role in shaping the company's future performance and competitive positioning in the medical technology sector.